Transcutaneous absorption of a topical rifamycin preparation: rifaximin (L/105).
The transcutaneous absorption of a new rifamycin preparation "Rifaximin", in comparison with that of rifampicin, was evaluated in the rat. Contrary to what was observed for rifampicin, Rifaximin was practically not absorbed.
D000279:Administration, Cutaneous; D000818:Animals; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012293:Rifampin / Q000378:metabolism; D012294:Rifamycins / Q000008:administration & dosage / Q000378:metabolism*; D000078262:Rifaximin; D012869:Skin Absorption
D012294:Rifamycins; D000078262:Rifaximin; D012293:Rifampin